newsfilter
← Latest News
GlobeNewswire·

N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination

Neve Yarak, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ:NITO) ("N2OFF"), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, following the completion